Latest in Foreign Sovereign Immunities Act
The district court’s dismissal of the State of Missouri’s billion-dollar lawsuit against China over its COVID response bodes ill for similar remaining coronavirus-related suits.
The relationship between foreign sovereign immunity and sanctions against central banks is important but often mischaracterized.
On Monday, Nov. 8, the U.S. Court of Appeals for the Ninth Circuit denied a motion to dismiss a lawsuit against NSO Group Technologies, an Israeli company.
Two recent Supreme Court rulings could be consequential for the interpretation of the Foreign Sovereign Immunities Act.
Does the “expropriation exception” of the Foreign Sovereign Immunities Act (FSIA) afford U.S. courts jurisdiction to resolve claims brought by German citizens against the German government?
Can courts abstain from hearing suits against foreign sovereigns for reasons of international comity, even when the Foreign Sovereign Immunities Act (FSIA) has provided the court jurisdiction over the suit by stripping the foreign sovereign of immunity?
A preliminary analysis of the legal questions likely to be raised in the lawsuits against the Saudi crown prince.
On Friday, the Office of the Director of National Intelligence (ODNI) released a declassified opinion by the Foreign Intelligence Surveillance Court (FISC) detailing limited circumstances under which the government may sequester information that was collected unlawfully.
The Senate Judiciary Committee held a hearing on “the Foreign Sovereign Immunities Act, Coronavirus, and Addressing China’s Culpability”—and the proceedings demonstrated that this corner of foreign relations law has become a political lightning rod.
Several individuals, small businesses and states have filed a total of at least 14 different suits against China (and affiliated entities and officials) based on its perceived culpability in causing the coronavirus pandemic.